Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.9500-0.1800 (-3.51%)
At close: 4:00PM EDT
4.9500 0.00 (0.00%)
After hours: 07:11PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close5.1300
Open5.2100
Bid4.8200 x 1200
Ask4.9500 x 3200
Day's Range4.7700 - 5.2100
52 Week Range1.8600 - 9.5400
Volume1,195,798
Avg. Volume8,216,185
Market Cap209.985M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.1700
Earnings DateOct 27, 2021 - Nov 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CRVS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Corvus Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 05/06/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more
Advertisement
Advertisement